135 related articles for article (PubMed ID: 3257503)
21. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
Benjamin D; Bazar LS; Wallace B; Jacobson RJ
Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
[TBL] [Abstract][Full Text] [Related]
23. B cell growth factor activity of interferon-gamma. Recombinant human interferon-gamma promotes proliferation of anti-mu-activated human B lymphocytes.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Mingari C; Maggi E; Liang CM; Moretta L
J Immunol; 1986 May; 136(10):3513-6. PubMed ID: 3084631
[No Abstract] [Full Text] [Related]
24. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.
Kitani A; Hara M; Hirose T; Norioka K; Harigai M; Hirose W; Suzuki K; Kawakami M; Kawagoe M; Nakamura H
Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539
[TBL] [Abstract][Full Text] [Related]
26. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor.
Baeker TR; Rothstein TL
J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333
[TBL] [Abstract][Full Text] [Related]
27. Structural homology of interferon-gamma with B-cell growth factor and its proliferative effect on long term B-cell lines.
Sekhsaria S; Sahasrabuddhe CG
Lymphokine Res; 1989; 8(1):47-57. PubMed ID: 2497278
[TBL] [Abstract][Full Text] [Related]
28. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
[TBL] [Abstract][Full Text] [Related]
30. Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.
Wilkinson PC; Islam LN
Immunology; 1989 Jun; 67(2):237-43. PubMed ID: 2502496
[TBL] [Abstract][Full Text] [Related]
31. alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes.
Rodriguez MA; Prinz WA; Sibbitt WL; Bankhurst AD; Williams RC
J Immunol; 1983 Mar; 130(3):1215-9. PubMed ID: 6296232
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
Blanchard DA; Affredou MT; Vazquez A
J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
[TBL] [Abstract][Full Text] [Related]
33. The effects of interleukin-1, interleukin-2, alpha-interferon, and gamma-interferon on human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
Trans Assoc Am Physicians; 1984; 97():182-9. PubMed ID: 6442950
[TBL] [Abstract][Full Text] [Related]
34. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
[TBL] [Abstract][Full Text] [Related]
35. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
37. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen J; de Vries JE
J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
[TBL] [Abstract][Full Text] [Related]
38. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
Bowen DL; Fauci AS
J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
[TBL] [Abstract][Full Text] [Related]
39. Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation.
Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Nadler LM
J Immunol; 1988 Nov; 141(10):3398-404. PubMed ID: 3141499
[TBL] [Abstract][Full Text] [Related]
40. Expression of the B8.7 antigen on hairy cells and relation with the LMW-BCGF response.
Génot E; Leprince C; Richard Y; Petit-Koskas E; Falcoff E; Galanaud P; Sigaux F; Kolb JP
Leukemia; 1989 May; 3(5):367-72. PubMed ID: 2785622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
